NEONC TECHNOLOGIES HOLDINGS, INC.
Develops an intranasal drug delivery platform to bypass the blood-brain barrier.
NTHI | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 23975 PARK SORRENTO, 91302 CALABASAS
- Website:
- https://neonc.com/
- Sector:
- Manufacturing
Description
NeOnc Technologies Holdings, Inc. is a clinical-stage life sciences company that has developed a proprietary, patented platform technology for transporting therapeutics directly to the brain. Its core innovation is an intranasal drug delivery system designed to overcome the limitations of the Blood-Brain Barrier (BBB), enabling more effective treatment for Central Nervous System (CNS) diseases. The company's primary focus is on developing novel therapies for brain cancers, such as glioblastoma, with pipeline candidates including NEO100 and NEO212. The platform is also designed to facilitate the transport of established and new third-party therapeutics, aiming to improve efficacy for a wide range of brain-related conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NEONC TECHNOLOGIES HOLDINGS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NEONC TECHNOLOGIES HOLDINGS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NEONC TECHNOLOGIES HOLDINGS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
